Changzhou Qianhong Biopharma CO.,LTD

Shenzhen Stock Exchange:002550.SZ

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

Location

China

Market Cap

USD 1.79 B

Share Price

USD 1.40

Avg Daily Volume

117,776,480

Change (1 day)

-0.04%

Change (1 year)

76.28%

Change (YTD)

64.75%

Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2024: 30.32%

Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin is 30.32% for the year ending December 31, 2024, a 94.45% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2023 was 15.59%, a -18.86% change year over year.
Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2022 was 19.22%, a 28.01% change year over year.
Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2021 was 15.01%, a -432.26% change year over year.
Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2020 was -4.52%, a -120.65% change year over year.